nodes	percent_of_prediction	percent_of_DWPC	metapath
Gadopentetate dimeglumine—PGD—Dacarbazine—sarcoma	0.853	1	CbGbCtD
Gadopentetate dimeglumine—PGD—mammary gland—sarcoma	0.00331	0.131	CbGeAlD
Gadopentetate dimeglumine—PGD—myometrium—sarcoma	0.00235	0.0928	CbGeAlD
Gadopentetate dimeglumine—PGD—seminal vesicle—sarcoma	0.00212	0.0838	CbGeAlD
Gadopentetate dimeglumine—PGD—hematopoietic system—sarcoma	0.00201	0.0797	CbGeAlD
Gadopentetate dimeglumine—PGD—connective tissue—sarcoma	0.00194	0.0767	CbGeAlD
Gadopentetate dimeglumine—PGD—smooth muscle tissue—sarcoma	0.00177	0.0702	CbGeAlD
Gadopentetate dimeglumine—PGD—skin of body—sarcoma	0.00175	0.0693	CbGeAlD
Gadopentetate dimeglumine—PGD—cardiac atrium—sarcoma	0.00153	0.0605	CbGeAlD
Gadopentetate dimeglumine—PGD—uterus—sarcoma	0.00152	0.0602	CbGeAlD
Gadopentetate dimeglumine—PGD—lymphoid tissue—sarcoma	0.00142	0.0561	CbGeAlD
Gadopentetate dimeglumine—PGD—tendon—sarcoma	0.00133	0.0527	CbGeAlD
Gadopentetate dimeglumine—PGD—bone marrow—sarcoma	0.00129	0.0511	CbGeAlD
Gadopentetate dimeglumine—PGD—testis—sarcoma	0.0011	0.0437	CbGeAlD
Gadopentetate dimeglumine—PGD—liver—sarcoma	0.00104	0.0413	CbGeAlD
Gadopentetate dimeglumine—PGD—lymph node—sarcoma	0.0008	0.0316	CbGeAlD
Gadopentetate dimeglumine—Paraesthesia—Mitoxantrone—sarcoma	0.000195	0.00161	CcSEcCtD
Gadopentetate dimeglumine—Loss of consciousness—Etoposide—sarcoma	0.000195	0.0016	CcSEcCtD
Gadopentetate dimeglumine—Decreased appetite—Vincristine—sarcoma	0.000194	0.0016	CcSEcCtD
Gadopentetate dimeglumine—Dyspnoea—Mitoxantrone—sarcoma	0.000194	0.0016	CcSEcCtD
Gadopentetate dimeglumine—Cough—Etoposide—sarcoma	0.000194	0.00159	CcSEcCtD
Gadopentetate dimeglumine—Somnolence—Mitoxantrone—sarcoma	0.000194	0.00159	CcSEcCtD
Gadopentetate dimeglumine—Blood creatinine increased—Epirubicin—sarcoma	0.000193	0.00159	CcSEcCtD
Gadopentetate dimeglumine—Gastrointestinal disorder—Vincristine—sarcoma	0.000193	0.00159	CcSEcCtD
Gadopentetate dimeglumine—Fatigue—Vincristine—sarcoma	0.000193	0.00158	CcSEcCtD
Gadopentetate dimeglumine—Convulsion—Etoposide—sarcoma	0.000192	0.00158	CcSEcCtD
Gadopentetate dimeglumine—Hypertension—Etoposide—sarcoma	0.000192	0.00158	CcSEcCtD
Gadopentetate dimeglumine—Constipation—Vincristine—sarcoma	0.000191	0.00157	CcSEcCtD
Gadopentetate dimeglumine—Pain—Vincristine—sarcoma	0.000191	0.00157	CcSEcCtD
Gadopentetate dimeglumine—Pain in extremity—Doxorubicin—sarcoma	0.000191	0.00157	CcSEcCtD
Gadopentetate dimeglumine—Diplopia—Doxorubicin—sarcoma	0.000191	0.00157	CcSEcCtD
Gadopentetate dimeglumine—Decreased appetite—Mitoxantrone—sarcoma	0.000189	0.00156	CcSEcCtD
Gadopentetate dimeglumine—Chest pain—Etoposide—sarcoma	0.000189	0.00155	CcSEcCtD
Gadopentetate dimeglumine—Abdominal pain upper—Epirubicin—sarcoma	0.000189	0.00155	CcSEcCtD
Gadopentetate dimeglumine—Migraine—Doxorubicin—sarcoma	0.000188	0.00155	CcSEcCtD
Gadopentetate dimeglumine—Fatigue—Mitoxantrone—sarcoma	0.000188	0.00154	CcSEcCtD
Gadopentetate dimeglumine—Unspecified disorder of skin and subcutaneous tissue—Etoposide—sarcoma	0.000188	0.00154	CcSEcCtD
Gadopentetate dimeglumine—Constipation—Mitoxantrone—sarcoma	0.000186	0.00153	CcSEcCtD
Gadopentetate dimeglumine—Pain—Mitoxantrone—sarcoma	0.000186	0.00153	CcSEcCtD
Gadopentetate dimeglumine—Toxic epidermal necrolysis—Epirubicin—sarcoma	0.000186	0.00153	CcSEcCtD
Gadopentetate dimeglumine—Hypersensitivity—Thiotepa—sarcoma	0.000186	0.00153	CcSEcCtD
Gadopentetate dimeglumine—Nasopharyngitis—Epirubicin—sarcoma	0.000185	0.00152	CcSEcCtD
Gadopentetate dimeglumine—Face oedema—Doxorubicin—sarcoma	0.000184	0.00152	CcSEcCtD
Gadopentetate dimeglumine—Hypersensitivity—Dactinomycin—sarcoma	0.000184	0.00152	CcSEcCtD
Gadopentetate dimeglumine—Gastrointestinal pain—Vincristine—sarcoma	0.000183	0.0015	CcSEcCtD
Gadopentetate dimeglumine—Confusional state—Etoposide—sarcoma	0.000183	0.0015	CcSEcCtD
Gadopentetate dimeglumine—Cardiac arrest—Doxorubicin—sarcoma	0.000182	0.00149	CcSEcCtD
Gadopentetate dimeglumine—Anaphylactic shock—Etoposide—sarcoma	0.000181	0.00149	CcSEcCtD
Gadopentetate dimeglumine—Asthenia—Thiotepa—sarcoma	0.000181	0.00149	CcSEcCtD
Gadopentetate dimeglumine—Asthenia—Dactinomycin—sarcoma	0.000179	0.00148	CcSEcCtD
Gadopentetate dimeglumine—Feeling abnormal—Mitoxantrone—sarcoma	0.000179	0.00148	CcSEcCtD
Gadopentetate dimeglumine—Blood creatinine increased—Doxorubicin—sarcoma	0.000179	0.00147	CcSEcCtD
Gadopentetate dimeglumine—Pruritus—Thiotepa—sarcoma	0.000178	0.00147	CcSEcCtD
Gadopentetate dimeglumine—Gastrointestinal pain—Mitoxantrone—sarcoma	0.000178	0.00146	CcSEcCtD
Gadopentetate dimeglumine—Tachycardia—Etoposide—sarcoma	0.000177	0.00145	CcSEcCtD
Gadopentetate dimeglumine—Body temperature increased—Vincristine—sarcoma	0.000177	0.00145	CcSEcCtD
Gadopentetate dimeglumine—Abdominal pain—Vincristine—sarcoma	0.000177	0.00145	CcSEcCtD
Gadopentetate dimeglumine—Skin disorder—Etoposide—sarcoma	0.000176	0.00145	CcSEcCtD
Gadopentetate dimeglumine—Hyperhidrosis—Etoposide—sarcoma	0.000175	0.00144	CcSEcCtD
Gadopentetate dimeglumine—Abdominal pain upper—Doxorubicin—sarcoma	0.000175	0.00144	CcSEcCtD
Gadopentetate dimeglumine—Angina pectoris—Epirubicin—sarcoma	0.000174	0.00143	CcSEcCtD
Gadopentetate dimeglumine—Urticaria—Mitoxantrone—sarcoma	0.000173	0.00142	CcSEcCtD
Gadopentetate dimeglumine—Anorexia—Etoposide—sarcoma	0.000173	0.00142	CcSEcCtD
Gadopentetate dimeglumine—Diarrhoea—Thiotepa—sarcoma	0.000172	0.00142	CcSEcCtD
Gadopentetate dimeglumine—Abdominal pain—Mitoxantrone—sarcoma	0.000172	0.00142	CcSEcCtD
Gadopentetate dimeglumine—Body temperature increased—Mitoxantrone—sarcoma	0.000172	0.00142	CcSEcCtD
Gadopentetate dimeglumine—Toxic epidermal necrolysis—Doxorubicin—sarcoma	0.000172	0.00141	CcSEcCtD
Gadopentetate dimeglumine—Diarrhoea—Dactinomycin—sarcoma	0.000171	0.00141	CcSEcCtD
Gadopentetate dimeglumine—Nasopharyngitis—Doxorubicin—sarcoma	0.000171	0.00141	CcSEcCtD
Gadopentetate dimeglumine—Hypotension—Etoposide—sarcoma	0.000169	0.00139	CcSEcCtD
Gadopentetate dimeglumine—Dizziness—Thiotepa—sarcoma	0.000167	0.00137	CcSEcCtD
Gadopentetate dimeglumine—Pollakiuria—Epirubicin—sarcoma	0.000165	0.00136	CcSEcCtD
Gadopentetate dimeglumine—Hypersensitivity—Vincristine—sarcoma	0.000165	0.00135	CcSEcCtD
Gadopentetate dimeglumine—Paraesthesia—Etoposide—sarcoma	0.000163	0.00134	CcSEcCtD
Gadopentetate dimeglumine—Dyspnoea—Etoposide—sarcoma	0.000161	0.00133	CcSEcCtD
Gadopentetate dimeglumine—Somnolence—Etoposide—sarcoma	0.000161	0.00132	CcSEcCtD
Gadopentetate dimeglumine—Angina pectoris—Doxorubicin—sarcoma	0.000161	0.00132	CcSEcCtD
Gadopentetate dimeglumine—Hypersensitivity—Mitoxantrone—sarcoma	0.00016	0.00132	CcSEcCtD
Gadopentetate dimeglumine—Asthenia—Vincristine—sarcoma	0.00016	0.00132	CcSEcCtD
Gadopentetate dimeglumine—Vomiting—Thiotepa—sarcoma	0.00016	0.00132	CcSEcCtD
Gadopentetate dimeglumine—Drowsiness—Epirubicin—sarcoma	0.000159	0.00131	CcSEcCtD
Gadopentetate dimeglumine—Vomiting—Dactinomycin—sarcoma	0.000159	0.00131	CcSEcCtD
Gadopentetate dimeglumine—Rash—Thiotepa—sarcoma	0.000159	0.00131	CcSEcCtD
Gadopentetate dimeglumine—Dermatitis—Thiotepa—sarcoma	0.000159	0.00131	CcSEcCtD
Gadopentetate dimeglumine—Headache—Thiotepa—sarcoma	0.000158	0.0013	CcSEcCtD
Gadopentetate dimeglumine—Rash—Dactinomycin—sarcoma	0.000158	0.0013	CcSEcCtD
Gadopentetate dimeglumine—Decreased appetite—Etoposide—sarcoma	0.000157	0.00129	CcSEcCtD
Gadopentetate dimeglumine—Renal failure—Epirubicin—sarcoma	0.000156	0.00129	CcSEcCtD
Gadopentetate dimeglumine—Gastrointestinal disorder—Etoposide—sarcoma	0.000156	0.00129	CcSEcCtD
Gadopentetate dimeglumine—Asthenia—Mitoxantrone—sarcoma	0.000156	0.00128	CcSEcCtD
Gadopentetate dimeglumine—Fatigue—Etoposide—sarcoma	0.000156	0.00128	CcSEcCtD
Gadopentetate dimeglumine—Pain—Etoposide—sarcoma	0.000155	0.00127	CcSEcCtD
Gadopentetate dimeglumine—Constipation—Etoposide—sarcoma	0.000155	0.00127	CcSEcCtD
Gadopentetate dimeglumine—Conjunctivitis—Epirubicin—sarcoma	0.000155	0.00127	CcSEcCtD
Gadopentetate dimeglumine—Diarrhoea—Vincristine—sarcoma	0.000153	0.00126	CcSEcCtD
Gadopentetate dimeglumine—Sweating—Epirubicin—sarcoma	0.000153	0.00125	CcSEcCtD
Gadopentetate dimeglumine—Pollakiuria—Doxorubicin—sarcoma	0.000153	0.00125	CcSEcCtD
Gadopentetate dimeglumine—Hepatobiliary disease—Epirubicin—sarcoma	0.00015	0.00124	CcSEcCtD
Gadopentetate dimeglumine—Nausea—Thiotepa—sarcoma	0.00015	0.00123	CcSEcCtD
Gadopentetate dimeglumine—Feeling abnormal—Etoposide—sarcoma	0.000149	0.00123	CcSEcCtD
Gadopentetate dimeglumine—Diarrhoea—Mitoxantrone—sarcoma	0.000149	0.00122	CcSEcCtD
Gadopentetate dimeglumine—Nausea—Dactinomycin—sarcoma	0.000149	0.00122	CcSEcCtD
Gadopentetate dimeglumine—Gastrointestinal pain—Etoposide—sarcoma	0.000148	0.00122	CcSEcCtD
Gadopentetate dimeglumine—Dizziness—Vincristine—sarcoma	0.000148	0.00122	CcSEcCtD
Gadopentetate dimeglumine—Drowsiness—Doxorubicin—sarcoma	0.000147	0.00121	CcSEcCtD
Gadopentetate dimeglumine—Bradycardia—Epirubicin—sarcoma	0.000145	0.0012	CcSEcCtD
Gadopentetate dimeglumine—Renal failure—Doxorubicin—sarcoma	0.000145	0.00119	CcSEcCtD
Gadopentetate dimeglumine—Urticaria—Etoposide—sarcoma	0.000144	0.00118	CcSEcCtD
Gadopentetate dimeglumine—Rhinitis—Epirubicin—sarcoma	0.000143	0.00118	CcSEcCtD
Gadopentetate dimeglumine—Abdominal pain—Etoposide—sarcoma	0.000143	0.00118	CcSEcCtD
Gadopentetate dimeglumine—Body temperature increased—Etoposide—sarcoma	0.000143	0.00118	CcSEcCtD
Gadopentetate dimeglumine—Conjunctivitis—Doxorubicin—sarcoma	0.000143	0.00118	CcSEcCtD
Gadopentetate dimeglumine—Vomiting—Vincristine—sarcoma	0.000142	0.00117	CcSEcCtD
Gadopentetate dimeglumine—Sweating—Doxorubicin—sarcoma	0.000141	0.00116	CcSEcCtD
Gadopentetate dimeglumine—Urinary tract disorder—Epirubicin—sarcoma	0.000141	0.00116	CcSEcCtD
Gadopentetate dimeglumine—Rash—Vincristine—sarcoma	0.000141	0.00116	CcSEcCtD
Gadopentetate dimeglumine—Dermatitis—Vincristine—sarcoma	0.000141	0.00116	CcSEcCtD
Gadopentetate dimeglumine—Oedema peripheral—Epirubicin—sarcoma	0.000141	0.00116	CcSEcCtD
Gadopentetate dimeglumine—Connective tissue disorder—Epirubicin—sarcoma	0.00014	0.00115	CcSEcCtD
Gadopentetate dimeglumine—Urethral disorder—Epirubicin—sarcoma	0.00014	0.00115	CcSEcCtD
Gadopentetate dimeglumine—Headache—Vincristine—sarcoma	0.00014	0.00115	CcSEcCtD
Gadopentetate dimeglumine—Hepatobiliary disease—Doxorubicin—sarcoma	0.000139	0.00115	CcSEcCtD
Gadopentetate dimeglumine—Vomiting—Mitoxantrone—sarcoma	0.000138	0.00114	CcSEcCtD
Gadopentetate dimeglumine—Visual impairment—Epirubicin—sarcoma	0.000138	0.00113	CcSEcCtD
Gadopentetate dimeglumine—Rash—Mitoxantrone—sarcoma	0.000137	0.00113	CcSEcCtD
Gadopentetate dimeglumine—Dermatitis—Mitoxantrone—sarcoma	0.000137	0.00113	CcSEcCtD
Gadopentetate dimeglumine—Headache—Mitoxantrone—sarcoma	0.000136	0.00112	CcSEcCtD
Gadopentetate dimeglumine—Erythema multiforme—Epirubicin—sarcoma	0.000135	0.00111	CcSEcCtD
Gadopentetate dimeglumine—Bradycardia—Doxorubicin—sarcoma	0.000135	0.00111	CcSEcCtD
Gadopentetate dimeglumine—Eye disorder—Epirubicin—sarcoma	0.000133	0.0011	CcSEcCtD
Gadopentetate dimeglumine—Hypersensitivity—Etoposide—sarcoma	0.000133	0.0011	CcSEcCtD
Gadopentetate dimeglumine—Tinnitus—Epirubicin—sarcoma	0.000133	0.0011	CcSEcCtD
Gadopentetate dimeglumine—Nausea—Vincristine—sarcoma	0.000133	0.00109	CcSEcCtD
Gadopentetate dimeglumine—Cardiac disorder—Epirubicin—sarcoma	0.000133	0.00109	CcSEcCtD
Gadopentetate dimeglumine—Flushing—Epirubicin—sarcoma	0.000133	0.00109	CcSEcCtD
Gadopentetate dimeglumine—Rhinitis—Doxorubicin—sarcoma	0.000133	0.00109	CcSEcCtD
Gadopentetate dimeglumine—Urinary tract disorder—Doxorubicin—sarcoma	0.000131	0.00107	CcSEcCtD
Gadopentetate dimeglumine—Oedema peripheral—Doxorubicin—sarcoma	0.00013	0.00107	CcSEcCtD
Gadopentetate dimeglumine—Asthenia—Etoposide—sarcoma	0.00013	0.00107	CcSEcCtD
Gadopentetate dimeglumine—Connective tissue disorder—Doxorubicin—sarcoma	0.00013	0.00107	CcSEcCtD
Gadopentetate dimeglumine—Angiopathy—Epirubicin—sarcoma	0.00013	0.00107	CcSEcCtD
Gadopentetate dimeglumine—Urethral disorder—Doxorubicin—sarcoma	0.00013	0.00107	CcSEcCtD
Gadopentetate dimeglumine—Nausea—Mitoxantrone—sarcoma	0.000129	0.00106	CcSEcCtD
Gadopentetate dimeglumine—Immune system disorder—Epirubicin—sarcoma	0.000129	0.00106	CcSEcCtD
Gadopentetate dimeglumine—Mediastinal disorder—Epirubicin—sarcoma	0.000129	0.00106	CcSEcCtD
Gadopentetate dimeglumine—Chills—Epirubicin—sarcoma	0.000128	0.00105	CcSEcCtD
Gadopentetate dimeglumine—Pruritus—Etoposide—sarcoma	0.000128	0.00105	CcSEcCtD
Gadopentetate dimeglumine—Arrhythmia—Epirubicin—sarcoma	0.000128	0.00105	CcSEcCtD
Gadopentetate dimeglumine—Visual impairment—Doxorubicin—sarcoma	0.000127	0.00105	CcSEcCtD
Gadopentetate dimeglumine—Mental disorder—Epirubicin—sarcoma	0.000125	0.00103	CcSEcCtD
Gadopentetate dimeglumine—Erythema multiforme—Doxorubicin—sarcoma	0.000125	0.00103	CcSEcCtD
Gadopentetate dimeglumine—Erythema—Epirubicin—sarcoma	0.000124	0.00102	CcSEcCtD
Gadopentetate dimeglumine—Diarrhoea—Etoposide—sarcoma	0.000124	0.00102	CcSEcCtD
Gadopentetate dimeglumine—Eye disorder—Doxorubicin—sarcoma	0.000124	0.00102	CcSEcCtD
Gadopentetate dimeglumine—Tinnitus—Doxorubicin—sarcoma	0.000123	0.00101	CcSEcCtD
Gadopentetate dimeglumine—Flushing—Doxorubicin—sarcoma	0.000123	0.00101	CcSEcCtD
Gadopentetate dimeglumine—Cardiac disorder—Doxorubicin—sarcoma	0.000123	0.00101	CcSEcCtD
Gadopentetate dimeglumine—Tension—Epirubicin—sarcoma	0.000122	0.001	CcSEcCtD
Gadopentetate dimeglumine—Dysgeusia—Epirubicin—sarcoma	0.000122	0.001	CcSEcCtD
Gadopentetate dimeglumine—Back pain—Epirubicin—sarcoma	0.00012	0.000989	CcSEcCtD
Gadopentetate dimeglumine—Angiopathy—Doxorubicin—sarcoma	0.00012	0.000986	CcSEcCtD
Gadopentetate dimeglumine—Dizziness—Etoposide—sarcoma	0.00012	0.000985	CcSEcCtD
Gadopentetate dimeglumine—Immune system disorder—Doxorubicin—sarcoma	0.000119	0.000982	CcSEcCtD
Gadopentetate dimeglumine—Mediastinal disorder—Doxorubicin—sarcoma	0.000119	0.00098	CcSEcCtD
Gadopentetate dimeglumine—Chills—Doxorubicin—sarcoma	0.000119	0.000975	CcSEcCtD
Gadopentetate dimeglumine—Arrhythmia—Doxorubicin—sarcoma	0.000118	0.000971	CcSEcCtD
Gadopentetate dimeglumine—Mental disorder—Doxorubicin—sarcoma	0.000116	0.000952	CcSEcCtD
Gadopentetate dimeglumine—Vomiting—Etoposide—sarcoma	0.000115	0.000947	CcSEcCtD
Gadopentetate dimeglumine—Erythema—Doxorubicin—sarcoma	0.000115	0.000946	CcSEcCtD
Gadopentetate dimeglumine—Agitation—Epirubicin—sarcoma	0.000114	0.00094	CcSEcCtD
Gadopentetate dimeglumine—Rash—Etoposide—sarcoma	0.000114	0.000939	CcSEcCtD
Gadopentetate dimeglumine—Dermatitis—Etoposide—sarcoma	0.000114	0.000938	CcSEcCtD
Gadopentetate dimeglumine—Headache—Etoposide—sarcoma	0.000113	0.000933	CcSEcCtD
Gadopentetate dimeglumine—Tension—Doxorubicin—sarcoma	0.000113	0.000929	CcSEcCtD
Gadopentetate dimeglumine—Dysgeusia—Doxorubicin—sarcoma	0.000113	0.000927	CcSEcCtD
Gadopentetate dimeglumine—Malaise—Epirubicin—sarcoma	0.000112	0.000922	CcSEcCtD
Gadopentetate dimeglumine—Syncope—Epirubicin—sarcoma	0.000112	0.000917	CcSEcCtD
Gadopentetate dimeglumine—Back pain—Doxorubicin—sarcoma	0.000111	0.000915	CcSEcCtD
Gadopentetate dimeglumine—Loss of consciousness—Epirubicin—sarcoma	0.000109	0.000899	CcSEcCtD
Gadopentetate dimeglumine—Cough—Epirubicin—sarcoma	0.000109	0.000892	CcSEcCtD
Gadopentetate dimeglumine—Convulsion—Epirubicin—sarcoma	0.000108	0.000886	CcSEcCtD
Gadopentetate dimeglumine—Nausea—Etoposide—sarcoma	0.000108	0.000884	CcSEcCtD
Gadopentetate dimeglumine—Hypertension—Epirubicin—sarcoma	0.000107	0.000883	CcSEcCtD
Gadopentetate dimeglumine—Chest pain—Epirubicin—sarcoma	0.000106	0.000871	CcSEcCtD
Gadopentetate dimeglumine—Arthralgia—Epirubicin—sarcoma	0.000106	0.000871	CcSEcCtD
Gadopentetate dimeglumine—Agitation—Doxorubicin—sarcoma	0.000106	0.00087	CcSEcCtD
Gadopentetate dimeglumine—Anxiety—Epirubicin—sarcoma	0.000106	0.000868	CcSEcCtD
Gadopentetate dimeglumine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—sarcoma	0.000105	0.000865	CcSEcCtD
Gadopentetate dimeglumine—Malaise—Doxorubicin—sarcoma	0.000104	0.000853	CcSEcCtD
Gadopentetate dimeglumine—Dry mouth—Epirubicin—sarcoma	0.000104	0.000851	CcSEcCtD
Gadopentetate dimeglumine—Syncope—Doxorubicin—sarcoma	0.000103	0.000849	CcSEcCtD
Gadopentetate dimeglumine—Confusional state—Epirubicin—sarcoma	0.000102	0.000842	CcSEcCtD
Gadopentetate dimeglumine—Anaphylactic shock—Epirubicin—sarcoma	0.000101	0.000835	CcSEcCtD
Gadopentetate dimeglumine—Loss of consciousness—Doxorubicin—sarcoma	0.000101	0.000832	CcSEcCtD
Gadopentetate dimeglumine—Cough—Doxorubicin—sarcoma	0.0001	0.000826	CcSEcCtD
Gadopentetate dimeglumine—Shock—Epirubicin—sarcoma	9.98e-05	0.000821	CcSEcCtD
Gadopentetate dimeglumine—Convulsion—Doxorubicin—sarcoma	9.97e-05	0.00082	CcSEcCtD
Gadopentetate dimeglumine—Nervous system disorder—Epirubicin—sarcoma	9.95e-05	0.000818	CcSEcCtD
Gadopentetate dimeglumine—Hypertension—Doxorubicin—sarcoma	9.93e-05	0.000817	CcSEcCtD
Gadopentetate dimeglumine—Tachycardia—Epirubicin—sarcoma	9.91e-05	0.000815	CcSEcCtD
Gadopentetate dimeglumine—Skin disorder—Epirubicin—sarcoma	9.86e-05	0.000811	CcSEcCtD
Gadopentetate dimeglumine—Hyperhidrosis—Epirubicin—sarcoma	9.81e-05	0.000807	CcSEcCtD
Gadopentetate dimeglumine—Chest pain—Doxorubicin—sarcoma	9.8e-05	0.000806	CcSEcCtD
Gadopentetate dimeglumine—Arthralgia—Doxorubicin—sarcoma	9.8e-05	0.000806	CcSEcCtD
Gadopentetate dimeglumine—Anxiety—Doxorubicin—sarcoma	9.76e-05	0.000803	CcSEcCtD
Gadopentetate dimeglumine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—sarcoma	9.73e-05	0.0008	CcSEcCtD
Gadopentetate dimeglumine—Anorexia—Epirubicin—sarcoma	9.67e-05	0.000796	CcSEcCtD
Gadopentetate dimeglumine—Dry mouth—Doxorubicin—sarcoma	9.58e-05	0.000788	CcSEcCtD
Gadopentetate dimeglumine—Hypotension—Epirubicin—sarcoma	9.48e-05	0.00078	CcSEcCtD
Gadopentetate dimeglumine—Confusional state—Doxorubicin—sarcoma	9.47e-05	0.000779	CcSEcCtD
Gadopentetate dimeglumine—Anaphylactic shock—Doxorubicin—sarcoma	9.39e-05	0.000772	CcSEcCtD
Gadopentetate dimeglumine—Musculoskeletal discomfort—Epirubicin—sarcoma	9.25e-05	0.00076	CcSEcCtD
Gadopentetate dimeglumine—Shock—Doxorubicin—sarcoma	9.24e-05	0.00076	CcSEcCtD
Gadopentetate dimeglumine—Nervous system disorder—Doxorubicin—sarcoma	9.21e-05	0.000757	CcSEcCtD
Gadopentetate dimeglumine—Tachycardia—Doxorubicin—sarcoma	9.16e-05	0.000754	CcSEcCtD
Gadopentetate dimeglumine—Skin disorder—Doxorubicin—sarcoma	9.12e-05	0.00075	CcSEcCtD
Gadopentetate dimeglumine—Paraesthesia—Epirubicin—sarcoma	9.11e-05	0.000749	CcSEcCtD
Gadopentetate dimeglumine—Hyperhidrosis—Doxorubicin—sarcoma	9.08e-05	0.000747	CcSEcCtD
Gadopentetate dimeglumine—Dyspnoea—Epirubicin—sarcoma	9.05e-05	0.000744	CcSEcCtD
Gadopentetate dimeglumine—Somnolence—Epirubicin—sarcoma	9.02e-05	0.000742	CcSEcCtD
Gadopentetate dimeglumine—Anorexia—Doxorubicin—sarcoma	8.95e-05	0.000736	CcSEcCtD
Gadopentetate dimeglumine—Decreased appetite—Epirubicin—sarcoma	8.82e-05	0.000726	CcSEcCtD
Gadopentetate dimeglumine—Hypotension—Doxorubicin—sarcoma	8.77e-05	0.000722	CcSEcCtD
Gadopentetate dimeglumine—Gastrointestinal disorder—Epirubicin—sarcoma	8.76e-05	0.000721	CcSEcCtD
Gadopentetate dimeglumine—Fatigue—Epirubicin—sarcoma	8.75e-05	0.00072	CcSEcCtD
Gadopentetate dimeglumine—Constipation—Epirubicin—sarcoma	8.68e-05	0.000714	CcSEcCtD
Gadopentetate dimeglumine—Pain—Epirubicin—sarcoma	8.68e-05	0.000714	CcSEcCtD
Gadopentetate dimeglumine—Musculoskeletal discomfort—Doxorubicin—sarcoma	8.56e-05	0.000704	CcSEcCtD
Gadopentetate dimeglumine—Paraesthesia—Doxorubicin—sarcoma	8.43e-05	0.000693	CcSEcCtD
Gadopentetate dimeglumine—Dyspnoea—Doxorubicin—sarcoma	8.37e-05	0.000688	CcSEcCtD
Gadopentetate dimeglumine—Feeling abnormal—Epirubicin—sarcoma	8.36e-05	0.000688	CcSEcCtD
Gadopentetate dimeglumine—Somnolence—Doxorubicin—sarcoma	8.35e-05	0.000687	CcSEcCtD
Gadopentetate dimeglumine—Gastrointestinal pain—Epirubicin—sarcoma	8.3e-05	0.000682	CcSEcCtD
Gadopentetate dimeglumine—Decreased appetite—Doxorubicin—sarcoma	8.16e-05	0.000671	CcSEcCtD
Gadopentetate dimeglumine—Gastrointestinal disorder—Doxorubicin—sarcoma	8.11e-05	0.000667	CcSEcCtD
Gadopentetate dimeglumine—Fatigue—Doxorubicin—sarcoma	8.1e-05	0.000666	CcSEcCtD
Gadopentetate dimeglumine—Urticaria—Epirubicin—sarcoma	8.06e-05	0.000663	CcSEcCtD
Gadopentetate dimeglumine—Constipation—Doxorubicin—sarcoma	8.03e-05	0.00066	CcSEcCtD
Gadopentetate dimeglumine—Pain—Doxorubicin—sarcoma	8.03e-05	0.00066	CcSEcCtD
Gadopentetate dimeglumine—Abdominal pain—Epirubicin—sarcoma	8.02e-05	0.00066	CcSEcCtD
Gadopentetate dimeglumine—Body temperature increased—Epirubicin—sarcoma	8.02e-05	0.00066	CcSEcCtD
Gadopentetate dimeglumine—Feeling abnormal—Doxorubicin—sarcoma	7.74e-05	0.000636	CcSEcCtD
Gadopentetate dimeglumine—Gastrointestinal pain—Doxorubicin—sarcoma	7.68e-05	0.000631	CcSEcCtD
Gadopentetate dimeglumine—Hypersensitivity—Epirubicin—sarcoma	7.48e-05	0.000615	CcSEcCtD
Gadopentetate dimeglumine—Urticaria—Doxorubicin—sarcoma	7.46e-05	0.000613	CcSEcCtD
Gadopentetate dimeglumine—Abdominal pain—Doxorubicin—sarcoma	7.42e-05	0.00061	CcSEcCtD
Gadopentetate dimeglumine—Body temperature increased—Doxorubicin—sarcoma	7.42e-05	0.00061	CcSEcCtD
Gadopentetate dimeglumine—Asthenia—Epirubicin—sarcoma	7.28e-05	0.000599	CcSEcCtD
Gadopentetate dimeglumine—Pruritus—Epirubicin—sarcoma	7.18e-05	0.00059	CcSEcCtD
Gadopentetate dimeglumine—Diarrhoea—Epirubicin—sarcoma	6.94e-05	0.000571	CcSEcCtD
Gadopentetate dimeglumine—Hypersensitivity—Doxorubicin—sarcoma	6.92e-05	0.000569	CcSEcCtD
Gadopentetate dimeglumine—Asthenia—Doxorubicin—sarcoma	6.74e-05	0.000554	CcSEcCtD
Gadopentetate dimeglumine—Dizziness—Epirubicin—sarcoma	6.71e-05	0.000552	CcSEcCtD
Gadopentetate dimeglumine—Pruritus—Doxorubicin—sarcoma	6.64e-05	0.000546	CcSEcCtD
Gadopentetate dimeglumine—Vomiting—Epirubicin—sarcoma	6.45e-05	0.000531	CcSEcCtD
Gadopentetate dimeglumine—Diarrhoea—Doxorubicin—sarcoma	6.43e-05	0.000528	CcSEcCtD
Gadopentetate dimeglumine—Rash—Epirubicin—sarcoma	6.4e-05	0.000526	CcSEcCtD
Gadopentetate dimeglumine—Dermatitis—Epirubicin—sarcoma	6.39e-05	0.000526	CcSEcCtD
Gadopentetate dimeglumine—Headache—Epirubicin—sarcoma	6.36e-05	0.000523	CcSEcCtD
Gadopentetate dimeglumine—Dizziness—Doxorubicin—sarcoma	6.21e-05	0.000511	CcSEcCtD
Gadopentetate dimeglumine—Nausea—Epirubicin—sarcoma	6.03e-05	0.000496	CcSEcCtD
Gadopentetate dimeglumine—Vomiting—Doxorubicin—sarcoma	5.97e-05	0.000491	CcSEcCtD
Gadopentetate dimeglumine—Rash—Doxorubicin—sarcoma	5.92e-05	0.000487	CcSEcCtD
Gadopentetate dimeglumine—Dermatitis—Doxorubicin—sarcoma	5.92e-05	0.000486	CcSEcCtD
Gadopentetate dimeglumine—Headache—Doxorubicin—sarcoma	5.88e-05	0.000484	CcSEcCtD
Gadopentetate dimeglumine—Nausea—Doxorubicin—sarcoma	5.58e-05	0.000459	CcSEcCtD
